Osteoclasts regulate homeostasis of bone development. A defect in osteoclast development results in osteopetrosis. Recently, the involvement of several molecules in osteoclast development has been found. Osteoclast-associated receptor (OSCAR) is one of such molecules critical for osteoclast differentiation. However, it remains unclear how OSCAR transduces signals for osteoclast differentiation. Here, we found that the FcRg chain, a signal transducing adaptor molecule for Fc receptors, is associated with OSCAR and is involved in the cell surface expression of OSCAR. Furthermore, FcRg is required for signal transduction by OSCAR. These ®ndings suggest that the FcRg-mediated signal transduction by OSCAR is involved in osteoclast differentiation.
Introduction
Bone homeostasis is dynamically controlled by the remodeling of new bone by osteoblasts and the resorption of old bone by osteoclasts. Disregulation of the functional balance between osteoblasts and osteoclasts results in severe bone disorder. As osteoclasts are the only population that resorbs bone, a defect in osteoclast function will result in osteopetrosis (1, 2) . Osteoclasts are derived from bone marrow (BM) precursor cells and belong to a lineage similar to that of macrophages and dendritic cells (1, 2) .
Recently, several studies have suggested that cell surface molecules such as triggering receptor expressed on myeloid cells 2 (TREM2) (3, 4) and OSCAR (5) are involved in osteoclast differentiation. TREM2 is widely expressed on cells that belong to myeloid lineage including osteoclasts (6, 7) . DAP12 is associated with TREM2 and mediates activation signals through TREM2 (7, 8) . It has been reported that a defect in TREM2-mediated signal transduction in human results in bone disorder (3, 4) . On the other hand, Kim et al. (5) have recently cloned OSCAR as a molecule expressed mainly on osteoclasts. They showed that osteoclast differentiation in vitro is signi®cantly inhibited by OSCAR±Ig fusion protein. These ®ndings suggest that OSCAR transduces signals involved in osteoclast differentiation upon recognition of its ligand. However, it remains unclear how OSCAR transduces an activation signal that is required for osteoclast differentiation.
It is known that various activating cell surface receptors on lymphocytes are associated with immunoreceptor tyrosine kinase activation motif (ITAM)-bearing signal transducing adaptor molecules such as CD3z, FcRg (FceRIg) and DAP12 (9) . These ITAM-bearing molecules are required for signal transduction by these receptors. One common feature of these signal transducing adaptor molecules is that they possess negatively charged amino acids at the transmembrane domain (9) . On the other hand, activating receptors that are associated with these signal transducing adaptor molecules possess positively charged amino acids at the transmembrane domain. The interaction between the negatively charged amino acids and the positively charged amino acids of these molecules is a primary requisite for the association of these receptors. Indeed, a point mutation of these charged amino acids abrogates this interaction (10, 11) . In addition to these ITAM-bearing signal transducing adaptor molecules, DAP10, which transduces an ITAM-independent activation signal into lymphocytes, also possesses a negatively charged amino acid at the transmembrane domain and associates with activating NKG2D receptor (12) . Interestingly, OSCAR possesses a positively charged amino acid, arginine, within the transmembrane region. In the present study, we analyzed whether OSCAR associates with these ITAM-bearing signal transducing adaptor molecules and found that FcRg plays a vital role in OSCAR-mediated signal transduction.
Methods

Mice
C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan). FcRg-de®cient mice with C57BL/6 background (13) were maintained in our animal facility in the SPF condition.
Induction of BM-derived osteoclasts
BM cells from C57BL/6 mice were cultured in a-MEM (Sigma) supplemented with 10% FCS (Sigma), 10 ±7 M dexamethasone (Sigma), and 10 ±8 M vitamin D 3 [1a, 25(OH) 2 D 3 , Calbiochem] for 10 days. In some experiments, BM cells were cultured in a-MEM (Sigma) supplemented with 10% FCS (Sigma), 10 ng/ml macrophage colony stimulating factor (M-CSF) (R&D systems), and 30 ng/ml murine soluble receptor activator of NF-kB ligand (sRANKL) (PeproTech) for 10 days as indicated. Osteoclast development was analyzed using a tartrate-resistant acid phosphatase (TRAP) staining kit (Hokudo).
RT±PCR
RNA was extracted from the BM-derived osteoclasts by means of a QIA quick RNA extraction kit and cDNA was generated using Superscript II (Invitrogen) reverse transcriptase. Primers used for ampli®cation were as follows: CD3z, sense primer: 5¢-ATCATCACAGCCCTGTACCT-3¢, anti-sense primer: 5¢-CCTCTCCGCCTCTCGCCTTT-3¢; FcRg, sense primer: 5¢-AAGAATTCCAGCGCC-3¢, anti-sense primer: 5¢-GGA-ATTCGCTGCCTTTCGGACCTGGAT-3¢; DAP12, sense primer: 5¢-AGTGACACTTTCCCAAGATG-3¢, anti-sense primer: 5¢-TGATAAGGCGACTCAGTCTC-3¢; DAP10, sense primer: 5¢-CCGGATGTGGGACTCTGTCT-3¢, anti-sense primer: 5¢-CTC-TGCCAGGCATGTTGATG; and b-actin, sense primer: 5¢-TCT-ACAATGAGCTGCGTGTG-3¢, anti-sense primer: 5¢-GGTACG-ACCAGAGGCATACA-3¢. Sequentially diluted cDNAs were ampli®ed in PCR under the following conditions: 94°C for 1 min, 57°C for 1 min, and 72°C for 1.5 min with 20 cycles for b-actin and 27 cycles for others.
Transfection of OSCAR and FcRg
cDNA encoding OSCAR without signal sequence was cloned into a pMx-neo retrovirus expression vector containing human CD8 signal sequence and FLAG sequence. cDNAs encoding CD3z, FcRg, DAP12 and DAP10 were subcloned into a pMxinternal ribosome entry site (IRES)-green¯uorescent protein (GFP) retrovirus expression vector. Each expression vector was transfected into a Phoenix retrovirus packaging cell line and viral supernatants were added to BM-derived osteoclasts cultured for 5 days in the presence of M-CSF and RANKL, and MA5.8, a CD3z-negative T-cell hybridoma cell line that lacks CD3z, FcRg and DAP12 (14) . The transfected cells were selected by G418 (1 mg/ml) and stained with anti-FLAG M2 mAb (Sigma), followed by PE-anti-mouse-IgG antibody (Jackson Immunolaboratories).
Surface biotinylation, immunoprecipitation and western blotting
Cells were surface-biotinylated as previously described (15) . Biotinylated cells were lysed with lysis buffer containing 1% digitonin, 50 mM Tris±HCl (pH 7.6), 150 mM NaCl, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF and 10 mM iodoacetamide, at a concentration of 1 Q 10 7 cell/ml. Cell lysates were immunoprecipitated with anti-Flag mAb, separated on two-dimensional non-reducing and reducing SDS± PAGE, and transferred onto a polyvinylidene di¯uoride (PVDF) membrane (Immobilon-P; Millipore Corporation, Bedford, MA). The biotinylated proteins were detected using streptavidin±peroxidase (Vectastain Elite ABC kit; Vector Laboratories Incorporated, Burlingame, CA), the ECL system (Amersham International, Buckinghamshire, UK) and autoradiography. After termination of chemiluminescence, the membrane was blotted with anti-FcRg antibody (Upstate Biotechnology) followed by peroxidase-labeled anti-rabbit antibody (Amersham), and detected by the ECL system.
Stimulation of MA5.8 transfectants by immobilized anti-FLAG mAb
Anti-FLAG M2 (Sigma) or control (anti-human CD3, OKT3) mAbs were immobilized on a 96-well¯at-bottomed culture plate (Coaster, Cambridge, MA) by incubating for 2 h at 37°C at a concentration of 10 mg/ml in PBS. MA5.8 transfectants (1 Q 10 5 ) were stimulated by these immobilized mAbs or phorbol 12-myristate 13-acetate (PMA) (50 ng/ml) plus ionomycin (IM) (500 ng/ml) for 2 days. IL-2 in the culture supernatant was measured by ELISA (Pharmingen).
Results
Expression of FcRg and DAP12 but not CD3z and DAP10 in osteoclasts
Because OSCAR possesses a positively charged amino acid, arginine, within the transmembrane region, we analyzed whether OSCAR associates with such ITAM-bearing signal transducing adaptor molecules as CD3z, FcRg, DAP12 and DAP10. First, we analyzed the expression of these adaptor molecules in BM-derived osteoclasts. BM cells were cultured in the presence of dexamethasone and vitamin D3 for 10 days. After the 10 day culture,~80% of adherent cells were TRAPpositive (data not shown). RNA was extracted from BM cells cultured for 3 and 10 days, and mRNA expressions of OSCAR, CD3z, FcRg, DAP12 and DAP10 were analyzed by semiquantitative RT±PCR. Compared to splenocytes, osteoclastenriched cultured BM cells expressed a high level of OSCAR mRNA (Fig. 1) . TRAP staining and OSCAR expression demonstrated that the osteoclasts were differentiated in the culture. The expressions of CD3z, FcRg, DAP12 and DAP10 were clearly detected in splenocytes, although the expression levels of FcRg and DAP12 were relatively low. In contrast, FcRg and DAP12 but not CD3z and DAP10 were detected in this population enriched with BM-derived osteoclasts. Especially, CD3z was not detected in this population even after 3 days of culture. In addition, CD3z was not detected in the osteoclastenriched population from FcRg-de®cient mice. Taken together, although purity of osteoclasts was 80%, neither CD3z nor DAP10 seems to be expressed on osteoclasts.
Upregulation of cell surface expression of OSCAR by CD3z and FcRg
In order to analyze whether OSCAR associates with these ITAM-bearing adaptor molecules, FLAG-tagged OSCAR was transfected into MA5.8, a CD3z-negative T-cell hybridoma cell line that lacks all of these adaptor molecules (14) . Thereafter, CD3z, FcRg, DAP12 and DAP10 were further transfected into FLAG±OSCAR-expressing MA5.8, and the cell surface expression of OSCAR was analyzed by means of FLAG staining. When FLAG±OSCAR was transfected into MA5.8, the cells were weakly stained by anti-FLAG mAb, indicating that OSCAR is weakly expressed on the cell surface in the absence of these adaptor molecules ( Fig. 2A) . Then, CD3z, FcRg, DAP12 and DAP10 in the pMx-IRES-GFP retrovirus expression vector were transfected into FLAG±OSCAR-expressing MA5.8 (Fig. 2B) . When CD3z or FcRg was transfected, the expression of FLAG±OSCAR was signi®cantly augmented in the GFPpositive population. Because the expression of CD3z and FcRg is well correlated with GFP expression, this indicates that FLAG±OSCAR expression is upregulated by either CD3z or FcRg. On the other hand, the expression of OSCAR was not changed by the transfection of control vector (mock), DAP12 or DAP10. Altogether, these data suggest that CD3z and FcRg but not DAP12 or DAP10 are associated with OSCAR and induce the surface expression of OSCAR. However, because the transcripts of CD3z were not detected in BM-derived osteoclasts (Fig. 1) , the OSCAR±CD3z association may not be relevant to the physiological function of OSCAR.
Next, in order to see the association of FcRg with OSCAR in normal cells, we cultured bone marrow cells from wild-type and FcRg-de®cient mice in the presence of M-CSF and RANKL and transfected Flag±OSCAR into them (Fig. 2C) . Thereafter, expression of Flag±OSCAR was analyzed. As expected, expression of OSCAR was signi®cantly higher on cells from wild-type mice than those from FcRg-de®cient mice. These data also suggested that FcRg augments the cell surface expression of OSCAR.
Association of FcRg with OSCAR
We then analyzed the physical association of FcRg with OSCAR. MA5.8 cells expressing FLAG±OSCAR alone or FLAG±OSCAR and FcRg were surface-biotinylated and the cell lysate was immunoprecipitated with anti-Flag mAb, followed by analysis on two-dimensional non-reducing (NR) and reducing (R) SDS±PAGE. When FLAG±OSCAR was precipitated with anti-FLAG mAb from the cell lysate of MA5.8 expressing both FLAG±OSCAR and FcRg, FLAG± OSCAR was detected as a 29 kDa protein in the diagonal position (Fig. 3A) . In addition, a 9 kDa homodimer was coprecipitated with FLAG±OSCAR. In contrast, the 9 kDa homodimer was not detected in the cell lysate of MA5.8 expressing FLAG±OSCAR alone. The 9 kDa homodimer coprecipitated with FLAG±OSCAR was blotted with anti-FcRg antibody (Fig. 3B) , thereby con®rming that it is FcRg. At any rate, these data indicate that FcRg is physically associated with OSCAR on the cell surface.
Requirement of FcRg for signal transduction by OSCAR
We next analyzed whether the association of OSCAR with FcRg is required for the signal transduction by OSCAR. FLAG± OSCAR-expressing MA5.8 cells were further transfected with CD3z, FcRg and DAP12, and the transfectants were stimulated with immobilized anti-FLAG mAb (Fig. 4A) . When CD3z and FcRg were transfected, the transfectants produced a signi®-cant amount of IL-2. FcRg transfection induced greater production of IL-2 than CD3z transfection. In contrast, FLAG±OSCAR-expressing MA5.8 transfected with DAP12 or DAP10 showed no IL-2 production similar to mock transfectants, although the cells responded to stimulation with PMA plus ionomycin. Furthermore, when the cell surface expression of CD69 as an early activation marker was analyzed by¯ow cytometry, MA5.8 expressing FLAG±OSCAR and FcRg or CD3z but not DAP12 or DAP10 showed upregulation of CD69 expression upon stimulation with anti-FLAG mAb (Fig. 4B) . Again, FcRg induced a higher expression of CD69 than CD3z. These data demonstrate that both FcRg and CD3z transduce activation signals through OSCAR upon crosslinking and that FcRg transduces stronger signals than CD3z.
Next, we analyzed osteoclast development from FcRgde®cient mice. As shown in Fig. 5(A) , osteoclasts were differentiated from bone marrow cells from FcRg-de®cient mice. Furthermore, we statistically evaluated the differentiation of osteoclasts (Fig. 5B) . Similarly, we could not detect signi®cant difference between wild-type mice and FcRgde®cient mice. These data suggested that FcRg is not essential for the differentiation of osteoclasts.
Discussion
In the present study, we found that FcRg is associated with OSCAR and that FcRg mediates signal transduction by OSCAR. A previous report has shown that osteoclast differentiation induced by co-culture with osteoblasts is signi®cantly impaired when the interaction between OSCAR and a putative OSCAR ligand is blocked by OSCAR±Ig fusion protein (5) . Therefore, an FcRg-mediated signal transduction by OSCAR upon recognition of its putative ligand expressed on osteoblasts may be involved in osteoclast differentiation.
We showed that expression of OSCAR is signi®cantly upregulated in the presence of FcRg although OSCAR was expressed weakly on the cell surface in the absence of CD3z, FcRg and DAP12. We have previously shown that NK1.1 associates with FcRg and FcRg is required for signal transduction of NK1.1 (15) . In this case, FcRg was not involved in the expression of NK1.1. Similarly, KIR does not require DAP12 for cell surface expression (9) . Therefore, it is likely that OSCAR is expressed on the cell's surface without adaptors as its intrinsic nature, although we cannot formally exclude the possibility that OSCAR associates with an unknown adaptor molecule in MA5.8.
To date, however, no signi®cant bone disorder has been reported in FcRg-de®cient mice (13, 16) , and indeed, we did not detect any signi®cant bone disorder in FcRg-de®cient mice in spite of extensive bone analyses (data not shown). Furthermore, we did not observe any obvious defect in osteoclast development when BM cells from FcRg-de®cient mice were cultured in the presence of M-CSF and RANKL (data not shown). Similarly, osteoclasts were well developed from FcRg-de®cient BM cells cultured in the presence of dexamethasone and vitamin D3 wherein the interaction between osteoblasts and osteoclasts can be induced. Taken together, the FcRg-mediated signal transduction by OSCAR is not essential for osteoclast development. The OSCAR±FcRg-mediated signal may be redundant with other signals and be involved in an alternative signaling pathway for osteoclast differentiation.
It has been reported that DAP12-de®cient human (17) and mouse (18) show defects in osteoclast development. TREM2 utilizes DAP12 for signal transduction and is reported to be involved in osteoclast differentiation (3, 4) . Indeed, patients lacking DAP12 or TREM2 show bone disorder, the so-called Nasu±Hakola disease (19, 20) , as well as bone cysts and presenile dementia. Although bone disorder was also observed in DAP12-de®cient mice (18) , the disorder was very mild compared to that in M-CSF-de®cient mice (op/op) that exhibited complete loss of osteoclast differentiation (21) . Therefore, a DAP12-independent pathway such as the OSCAR±FcRg pathway may be involved in osteoclast development. Indeed, FcRg and DAP12 double-de®cient mice show severer bone disorders than DAP12-de®cient mice (Dr Takai, Tohoku University, Japan; personal communication). There- fore, both the TREM2±DAP12 and OSCAR±FcRg pathways may be redundantly involved in osteoclast differentiation.
We showed that both CD3z and FcRg associate with OSCAR and mediate activation signals by OSCAR. Although the transcription of CD3z in an osteoclast-enriched population was not detected by RT±PCR, we cannot rule out the possibility that a small amount of CD3z is expressed on a small number of osteoclast precursor cells in BM, which compensates the defect of FcRg. In addition, unknown adaptor molecules may also be involved in signal transduction of OSCAR. These possibilities may account for the reason why FcRg-de®cient mice do not show signi®cant osteoclast differentiation. Therefore, further analysis of osteoclast development using double-or triple-de®cient mice lacking CD3z, FcRg and/or DAP12 is necessary to clarify the redundancy and the physiological function of these molecules in osteoclast differentiation.
Kim et al. (5) showed that osteoblasts are stained well by OSCAR±Ig fusion protein, and suggested that the ligand for OSCAR is expressed on osteoblasts. Identi®cation of the ligand is essential for elucidating the physiological function of OSCAR in osteoclast development. Mouse OSCAR is localized near the proximal end of mouse chromosome 7, the region where the paired immunoglobulin-like receptor (PIR) family resides. In addition, human OSCAR is mapped at the leukocyte receptor complex (LRC) locus on human chromosome 19q13.4 where CD85/immunoglobulin (Ig)-like transcript (ILT)/leukocyte Ig-like receptor (LILR) and killer Ig-like receptor (KIR) are located. Similar to OSCAR, these receptors also contain an Ig-like structure and their activating forms utilize FcRg or DAP12 for signal transduction. OSCAR may have evolved with these receptors that regulate the immune function. Considering that some of the CD85 and KIR molecules recognize MHC class I, OSCAR might also recognize certain antigens with an MHC class I structure.
FcRg is associated with not only Fc receptors but also various immuno-receptors such as NK cell receptor (NKR) P1C (15), PIR-A (22), CD85/ILT/LILR (23), Nkp46 (24), platelet glycoprotein IV (25) and dendritic immunoactivating receptor (DCAR) (26) . In addition, we have previously reported a defect in the function of antigen presenting cells in FcRg-de®cient mice (27) . Therefore, FcRg-mediated signal transduction seems to be widely involved in immune regulation. Indeed, it is quite interesting that osteoclasts use the same signaling molecule for their function as various receptors in lymphocytes. Further analysis of the function of FcRg-associated receptors including OSCAR will lead to the elucidation of unknown immune activation mechanisms.
